Compare MASS & ARDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MASS | ARDC |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.4M | 332.5M |
| IPO Year | 2020 | N/A |
| Metric | MASS | ARDC |
|---|---|---|
| Price | $6.16 | $13.62 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 408.7K | 115.8K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.84% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,045,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 36.21 | N/A |
| 52 Week Low | $1.81 | $11.56 |
| 52 Week High | $9.34 | $14.30 |
| Indicator | MASS | ARDC |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 46.65 |
| Support Level | $6.13 | $13.26 |
| Resistance Level | $6.64 | $13.96 |
| Average True Range (ATR) | 0.40 | 0.17 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 58.93 | 47.95 |
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
Ares Dynamic Credit Allocation Fund Inc is a closed-ended, diversified management investment company. The fund's investment objective is to provide an attractive level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of senior secured loans (Senior Loans) made to companies whose debt is rated below investment grade; corporate bonds (Corporate Bonds) that are high yield issues rated below investment grade; other fixed-income instruments of a similar nature that may be represented by derivatives; and securities of collateralized loan obligations (CLOs).